Japan COVID-19 diagnostics market will see the considerable decline of 14.7% during the forecast period. Japan has a significant share in the global COVID-19 diagnostics market owing to the growing diagnostic tests in the country coupled with the introduction of new diagnostic test for COVID-19 in the country. In Japan, earlier the detection of SARS-CoV-2 was routinely utilized by a method called nucleic acid amplification test (NAT), including PCR. While these methods were relatively accurate, it takes a couple of hours to obtain test results. On the other side, the antigen test can provide test results within 30 minutes. In addition, an antigen test does not require a special device such as PCR or other NAT method does, allowing the results to be obtained right at the testing site. Therefore, the antigen test is expected to enhance the speed and accessibility in detection of the COVID-19 in the country.
Browse the full report description Japan COVID-19 diagnostics Market Size, Share & Trends Analysis Report by Type (Instruments, Reagents & Kits, and Laboratory Testing Services), by Technology Type (PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test), by Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Blood, Urine, Saliva, and Others), and by End-Users (Laboratories, Hospitals, Diagnostic Centers & Clinics, and Research Institutes) and Forecast, 2020-2026 at https://www.omrglobal.com/industry-reports/japan-covid-19-diagnostics-market
Through these advantages, it is anticipated that more patients can be tested for SARS-CoV-2, providing an additional testing option to the clinical settings that are largely affected by the pandemic in country. On July 31, 2020, TOSOH Corp. received the authorization for TRCReady SARS-CoV-2, Nucleic acid test for the COVID-19 diagnosis in the country. Furthermore, on June 19, 2020, Fujirebio Inc. received the approval for the Lumipulse G SARS-CoV-2 Ag that is an antigen test for the COVID-19 by the MHLW in the country. Therefore, with approval of these rapid IVD kits, the government of Japan and MHLW projected to expand the test capacity in the country that is further estimated to propel the market growth in the country.
Market Coverage
|
Report Elements |
Details |
|
Study Period |
2020-2026 |
|
Segments Covered |
By Type, By Technology Type, By Sample Type, and By End-Users |
|
Key Companies Profiled |
Otsuka Pharmaceutical
Co., Ltd., Sysmex Corp., TOSOH Corp., Fujirebio Inc., and Eiken Chemical Co.,
Ltd. |
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID-19
o Most affected segment
o Recommendations
Japan COVID-19 Diagnostics Market – Segmentation
By Type
By Technology Type
o Chromatographic Immunoassay
o Fluorescent Immunoassay
o Chemiluminescent Immunoassay
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Neutralization
o Chemiluminescent Immunoassay
By Sample Type
By End-Users
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/japan-covid-19-diagnostics-market